Lack of mutation in tumour-suppressor gene p53 in gestational trophoblastic tumours

British Journal of Cancer

Volumn 73, Issue 10, 1996, Pages 1216-1219

  Shi, Y F ^a   Xie, X ^a   Zhao, C L ^a   Ye, D F ^a   Lu, S M ^a   Jen Hor, J ^b   Pao, C C ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Gestational trophoblastic tumour; Mutation; p53; Polymerase chain reaction; Tumour suppressor gene

Indexed keywords

DNA; PROTEIN P53;

ARTICLE; CARCINOGENESIS; CHORIOCARCINOMA; CONTROLLED STUDY; DNA SEQUENCE; GENE MUTATION; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TROPHOBLAST; TROPHOBLASTIC TUMOR; TUMOR SUPPRESSOR GENE;

EID: 0029999742     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.233     Document Type: Article

References (26)

1. BERCHUCK A, KOHLER MF, MARKS JR, WISEMAN R, BOYD J AND BAST RC Jr. (1994). The p53 tumour suppressor gene frequently is altered in gynecologic cancers. Am. J. Obstet. Gynecol., 170, 246-252.
2. BOSARI S, RONCALLI M, VIALE G, BOSSI P AND COGGI G. (1993). p53 immunoreactivity in inflammatory and neoplastic diseases of the uterine cervix. J. Pathol., 169, 425-430.
3. CASTRESANA JS, RUBIO MP, VAZQUEZ JJ, IDOATE M, SOBER AJ, SEIZINGER BR AND BARNHILL RL. (1993). Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma. Int. J. Cancer, 55, 562-565.
4. CHANG YS, LIN YJ, TSAI CN, SHU CH, TSAI MS, CHOO KB AND LIU ST. (1992). Detection of mutations in the p53 gene in human head and neck carcinomas by single strand conformation polymorphism analysis. Cancer Lett., 67, 167-174.
5. CHEN CA, CHEN YH, CHEN TM, KO TM, WU CC, LEE CN AND HSIEH CY. (1994). Infrequent mutation in tumour suppressor gene p53 in gestational trophoblastic neoplasia. Carcinogenesis, 15, 2221-2223.
6. CHEUNG AN, SRIVASTAVA G, PITTALUGA S, MAN TK, NGAN H AND COLLINS RJ. (1993). Expression of c-myc and c-fms oncogenes in trophoblastic cells in hydatidiform mole and normal human placenta. J. Clin. Pathol., 46, 204-207.
7. COOPER K, HERRINGTON CS, EVANS MF, GATTER KC AND McGEE JO. (1993). p53 antigen in cervical condylomata, intraepithelial neoplasia and carcinoma: relationship to HPV infection and integration. J. Pathol., 171, 27-34.
8. EL ROUBY S, THOMAS A, COSTIN D, ROSENBERG CR, POTMESIL M, SILBER R AND NEWCOMB EW. (1993). p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression. Blood, 82, 3452-3459.
9. FLEISCHHACKER M, STROHMEYER T, IMAI Y, SLAMON DJ AND KEOFFLER HP. (1994). Mutations of the p53 gene are not detectable in human testicular tumors. Mod. Pathol., 7, 435-439.
10. FROMWITZ FB, VIOLA MV, CHAO S, ORAVEZ S, MISHRIKI Y, FINKEL G, GRIMSON R AND LUNDY J. (1987). Ras p21 expression in the progression of breast cancer. Hum. Pathol., 18, 1268-1275.
11. GREENBLATT MS, BENNETT WP, HOLLSTEIN M AND HARRIS CC. (1994). Mutations in the p53 tumour suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4858.
12. HARRIS CC AND HOLLSTEIN M. (1993). Clinical implications of the p53 tumor-suppressor gene. N. Engl. J. Med., 329, 1318-1327.
13. HOLLSTEIN M, SIDRANSKY D, VOGELSTEIN B AND HARRIS C. (1991). p53 mutations in human cancers. Science, 253, 49-53.
14. KIM NW, PIATYSZEK MA, PROWSE KR, HARLEY CB, WEST MD, HO PL, COVIELLO GM, WRIGHT WE, WEINRICH SL AND SHAY JW. (1994). Specific association of human telomerasc activity with immortal cells and cancer. Science, 266, 2011-2015.
15. LEVINE AJ, MOMAND J AND FINLAY CA. (1991). The p53 tumor suppressor gene. Nature, 351, 453-456.
16. LEVINE AJ, PERRY ME, CHANG A, SILVER A, DITTMER D, WU M AND WELSH D. (1994). The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis. Br. J. Cancer. 69, 409-416.
17. LITOFSKY NS, HINTON D AND RAFFEL C. (1994). The lack of a role for p53 in astrocytomas in pediatric patients. Neurosurgery, 34, 967-972.
18. LURAIN JR. (1990). Gestational trophoblastic tumors. Semin. Surg. Oncol., 6, 347-353.
19. MIYAMOTO S, SASAKI M, NISHIDA M AND WAKE N. (1991). Identification of a chromosome carrying a putative tumor suppressor gene in human choriocarcinoma by microcellmediated chromosome transfer. Human Cell, 4, 38-43.
20. PAO CC, LIN SS, LIN CY, MAA JS, LAI CH AND HSIEH TT. (1991). Identification of human papillomavirus in peripheral blood mononuclear cells by DNA amplification method. Am. J. Clin. Pathol., 95, 540-546.
21. PAO CC, HOR JJ, TSAI PL AND HORNG MY. (1993). Inhibition of in vitro enzymatic DNA amplification reaction by ultraviolet light irradiation. Mol. Cell. Probes, 7, 217-219.
22. PAO CC, KAO SM, CHEN JH, TANG GC, CHANG PY AND TAN TT. (1994). State of mutational alterations of the p53 and retinoblastoma susceptibility genes in papillomavirus-negative human small cell cervical carcinomas. J. Surg. Oncol., 57, 87-93.
23. ROBERTS DJ AND MUTTER GL. (1994). Advances in the molecular biology of gestational trophoblastic disease. J. Reprod. Med., 39, 201-208.
24. SOUSSI T, CARON DE FROMENTAL C AND MAY P. (1990). Structural aspects of the p53 protein in relation to gene revolution. Oncogene, 5, 945-952.
25. ULLRICH SJ, ANDERSON CW, MERCER WE AND APPELLA E, (1992). The p53 tumor suppressor protein, a modulator of cell proliferation. J. Biol. Chem.., 267, 15259-15262.
26. WYNFORD-THOMAS D, BOND JA, WYLLIE FS, and JONES CJ. (1995). Does telomere shortening drive selection for p53 mutation in human cancer? Mol. Carcinogenesis, 12, 119-123.